Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil

Background: Patients with pulmonary arterial hypertension (PAH) and additional cardiac or pulmonary comorbidities have a poor prognosis and are frequently excluded from clinical trials. The purpose of this study was to evaluate outcomes of patients with pulmonary hypertension (PH) secondary to a ran...

Full description

Bibliographic Details

Published in:	JHLT Open
Main Authors:	Aparna C. Swaminathan, Amber Meservey, Alice Parish, Cynthia L. Green, Kishan Parikh, Terry Fortin, Richard A. Krasuski, Jordan W. Whitson, Talal Dahhan, Yen-Rei Yu, Karla Kennedy, Susana Almeida-Peters, Sudarshan Rajagopal
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Subjects:	pulmonary arterial hypertension prostacyclin World Symposium on Pulmonary Hypertension pulmonary vasodilator treprostinil
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950133424000806